Click on the highlighted text and dots or the menu to link directly
to additional information about each of these topics.

Candidate Indication Mechanism of Action Programme Status Partner
      Discovery Phase Preclinical Development Clinical Phase I Clinical Phase II  
IFN-β (SNG001) Asthma Virus Defence
AstraZeneca
IFN-β (SNG001) COPD Virus Defence
AstraZeneca
LOXL2 inhibitor IPF Anti-fibrotic
Pharmaxis